Rapid Dose Therapeutics Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RDTCF research report →
Price Chart
About the company
Rapid Dose Therapeutics Corp. , a life sciences enterprise based in Burlington, Canada, specializes in cutting-edge drug delivery systems aimed at enhancing health and well-being for individuals across Canada. Their core offering is the QuickStrip/PharmaStrip, an innovative oral, fast-dissolving film designed to swiftly introduce active compounds—such as pharmaceuticals, emulsified oils, and over-the-counter remedies—directly into the bloodstream.
- CEO
- Mark Andrew Upsdell
- IPO
- 2019
- Employees
- 12
- HQ
- Burlington, ON, CA
Get TickerSpark's AI analysis on RDTCF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $9.54M
- P/E
- -3.78
- PEG
- -0.06
- P/S
- 4.72
- P/B
- -1.63
- EV/EBITDA
- -12.87
- Div Yield
- 0.00%
- Gross Margin
- -10.82%
- Op Margin
- -73.59%
- Net Margin
- -123.09%
- ROE
- 46.54%
- ROIC
- 109.29%
Latest fiscal year · YoY change
- Revenue
- $2.77M+33.0%
- Gross Profit
- $1.36M+15.5%
- Op Income
- $-1,657,772
- Net Income
- $-3,389,667+37.3%
- EPS
- $-0.03+36.3%
- OCF Growth
- +76.4%
- FCF Growth
- +76.5%
- 52W High
- $0.15
- 52W Low
- $0.01
- 50D MA
- $0.08
- 200D MA
- $0.08
- Beta
- -4.25
- RSI (14)
- 21
- Avg Volume
- 2.64K
No earnings-call transcripts are available for RDTCF yet.
- Free Float
- 85.1%
- Shares Outstanding
- 135.18M
- Float Shares
- 115.00M
Our RDTCF coverage
Recent articles, reports, and earnings notes.
No research on RDTCF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RDTCF report →Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt and Proposed Issuance of Shares as Payment of Accrued Director Fees
newsfilecorp.com · Oct 5
Rapid Dose Therapeutics and Aavishkar Granted Monolayer QuickStrip(TM) Nicotine Patent, Advancing RDT's Global Commercialization Strategy
feeds.newsfilecorp.com · Aug 20
Rapid Dose Therapeutics (DOSE) (RDTCF) and Bodhi Health Expand Distribution and Sales of CurcuWIN(R) QuickStrip(TM) Curcumin Across Canada
feeds.newsfilecorp.com · Jul 28
Rapid Dose Therapeutics Extends Strategic Collaboration with Global Nicotine Leader and Initiating Saudi Arabia Commercialization
feeds.newsfilecorp.com · Jul 7
Rapid Dose Therapeutics (DOSE) (RDTCF) Advances Pharmaceutical Manufacturing Expansion with Burlington Facility Upgrades Targeting Global Medical Markets
feeds.newsfilecorp.com · Apr 13
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt
newsfilecorp.com · Apr 6
Rapid Dose Therapeutics (DOSE) (RDTCF) Secures Patent for QuickStrip(TM) Nicotine Oral Film Targeting $38B Smoke-Free Nicotine Market
feeds.newsfilecorp.com · Mar 5
Rapid Dose Therapeutics Advances Cannabinoid Research and Clinical Evaluation of QuickStrip(TM) Platform
feeds.newsfilecorp.com · Feb 23
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.